RxDoctor Payments Data

Emma Scott

Hematology · Portland, ORNPI 1821204934

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $2,576 of the $2,576 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, GSK.

$2,576in general payments, 2019–2025

Across 4 payments — averaging $644.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$3K
$2,110,744in research payments, 2019–2025

Across 72 payments — averaging $29,316 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Amgen$1.8M
  • Janssen Research & Development, LLC$114K
  • Takeda Pharmaceuticals U.S.A., Inc.$71K
  • Incyte Corporation$46K
  • E.r. Squibb & Sons, L.L.C.$27K
  • Stemline Therapeutics Inc.$8K

What the payments were for

  • Travel & lodging$2,576100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GSK4$2,576

How this compares

$2,576 in reported general payments places this provider in the 55th percentile of 27 hematology providers in Oregon.

See all hematology providers in Oregon →

Other hematology in Portland

See the full list for Oregon →

Where these figures come from

Is this you, or does something look wrong? →